Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
biotech
boston blog main
boston top stories
3
×
deals
life sciences
national blog main
startups
3
×
boston
ipo
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
vc
480 biomedical
acetylon pharmaceuticals
ambys medicines
arsenal medical
azacitidine
beta-thalassemia
bob langer
cell therapy
chronic rhinosinusitis
clinical trials
constellation pharmaceuticals
covid-19
dacogen
decitabine
dna
drug delivery
epigenetics
epizyme
farydak
fda
flagship pioneering
fulcrum therapeutics
gene therapy
genentech
genzyme
What
biotech
3
×
new
3
×
developing
medicines
startup
therapeutics
aiming
aims
ambys
approach
based
big
called
company
control
deadly
deal
debut
debuted
debuts
diseases
drugs
epigenetic
epigenetics
field
flagship’s
formed
future
ipo
late
launch
liver
lyra
make
markets
million
morning
nose
noses
omega
Language
unset
Current search:
new
×
startups
×
photo
×
biotech
×
" boston top stories "
×
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?